Christine Coyne

Corporate Officer/Principal at ITERUM THERAPEUTICS PLC

58 year

Health Technology

Consumer Services

Profile

Christine R.
Coyne currently works at Iterum Therapeutics Plc, as Chief Commercial Officer from 2025.
Ms. Coyne also formerly worked at SCYNEXIS, Inc., as Chief Commercial Officer from 2021 to 2022 and Paratek Pharmaceuticals, Inc., as Senior Vice President-Commercial from 2020 to 2021.
Ms. Coyne received her Masters Business Admin degree from Eastern University and undergraduate degree from West Chester University of Pennsylvania.

Christine Coyne active positions

Companies	Position	Start
ITERUM THERAPEUTICS PLC	Corporate Officer/Principal	2025-06-29

All active positions of Christine Coyne

Former positions of Christine Coyne

Companies	Position	End
SCYNEXIS, INC.	Corporate Officer/Principal	2022-11-29
PARATEK PHARMACEUTICALS, INC.	Corporate Officer/Principal	2021-04-30

See the detail of Christine Coyne's experience

Training of Christine Coyne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christine Coyne's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
SCYNEXIS, Inc. SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections	Health Technology
Eastern University Eastern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
West Chester University of Pennsylvania West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Paratek Pharmaceuticals, Inc. Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Iterum Therapeutics Plc Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem	Health Technology